MineBio Life Sciences Limited

Relying on the one-stop supply chain system of MineBio’s parent company LabDirect China Limited and the advantages of import and export of high-risk biological products, MineBio provides quality solutions from R&D to clinical and commercial production of biological products in the field of cell gene therapy/stem cell/regenerative medicine and antibody-protein drugs, those are including: 1) research-grade to clinical-grade/cGMP animal-free culture matrix/transfection reagents/viral transduction 2) library customization and licensing of flexible CHO-engineered cell lines for protein, enzyme and antibody drugs; 3) 3D culture and organ-on-a-chip technology for organoid and regenerative medicine to support translational medicine research.